NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,272,880 | -22.1% | 402,810 | -4.6% | 0.00% | – |
| Q2 2023 | $1,633,442 | +42.4% | 422,078 | +1.9% | 0.00% | – |
| Q1 2023 | $1,147,283 | +71.5% | 414,182 | +11.5% | 0.00% | – |
| Q4 2022 | $668,906 | +6.3% | 371,614 | +25.4% | 0.00% | – |
| Q3 2022 | $629,000 | +97.8% | 296,255 | +150.9% | 0.00% | – |
| Q2 2022 | $318,000 | +43.2% | 118,062 | +131.1% | 0.00% | – |
| Q1 2022 | $222,000 | +0.5% | 51,095 | +20.4% | 0.00% | – |
| Q4 2021 | $221,000 | +16.9% | 42,431 | +38.0% | 0.00% | – |
| Q3 2021 | $189,000 | +3680.0% | 30,756 | +6051.2% | 0.00% | – |
| Q2 2021 | $5,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |